arrow
Y

Yukihiko Sonoda

Yamagata University
H指数:38
被引数:6,837

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods

日本髓母细胞瘤队列的分子与临床特征:采用经济/便捷的诊断方法进行亚组特异性预后分层

2026-03-110
OAAI
A multicenter phase II trial of convection-enhanced delivery of ACNU in children with DIPG: Comparison with Japanese historical control and examination of patient selection bias

一项关于ACNU对流增强递送在儿童DIPG中的多中心II期临床试验:与日本历史对照的比较及患者选择偏倚的考察

2025-11-010
PRE
Characteristics and outcomes of diffuse non-midline gliomas with H3F3A gene mutation in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort study

弥漫性非中线胶质瘤H3F3A基因突变的特征与结局:日本关西中枢神经系统肿瘤分子诊断网络(Kansai Network)中的多中心回顾性队列研究

2025-04-160
OA
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort study

肿瘤治疗领域对日本新诊断胶质母细胞瘤患者生存的影响: 一项多中心,回顾性队列研究

2024-11-280
OAAI
Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up study
2024-11-020
PRE
Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort (vol 12, 120, 2024)
2024-10-010
OAAI
Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort
2024-07-272
OAAI
LONG-TERM OUTCOMES AND COMPLICATION MANAGEMENT IN CNS GERM CELL TUMORS: INSIGHTS FROM A PHASE II HISTOPATHOLOGY-STRATIFIED TREATMENT TRIAL
2024-06-180
OAAI